Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Content Type

Project (27)
Programme (7)

Language

English (34)

Advanced search

Results 1 - 10 of 34
Results/page:
12 3 4 > 
A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer
ID: 731623
Start date: 2017-12-01, End date: 2022-11-30
Cervical cancer (CxCa) is caused by high risk types of the human papillomavirus (a.o. HPV16). Prophylactic HPV vaccination is not the standard of care in all European countries, and where approved it is not sufficiently adopted. Once infected, these vaccines no longer prevent...
Programme: H2020-EU.3.1.3.
Record Number: 212591
Last updated on: 2018-01-18
Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial
ID: 754640
Start date: 2018-01-01, End date: 2022-12-31
TENSION (efficacy and safety of ThrombEctomy iN Stroke with extended leSION and extended time window: a randomized, controlled trial) strives at providing innovative treatment to patients with severe stroke to reduce the individual and societal burden of death and dependency...
Programme: H2020-EU.3.1.3.
Record Number: 212667
Last updated on: 2018-01-18
PREvention of STroke in Intracerebral hemorrhaGE survivors with Atrial Fibrillation
ID: 754517
Start date: 2017-12-01, End date: 2022-11-30
Intracerebral hemorrhage (ICH) is a severe stroke subtype causing higher mortality and more disability than other strokes. 20% of ICH survivors have atrial fibrillation (AF), a major cause of ischemic stroke (IS). While IS in AF patients is generally prevented by oral...
Programme: H2020-EU.3.1.3.
Record Number: 212666
Last updated on: 2018-01-18
Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB
ID: 754848
Start date: 2018-01-01, End date: 2022-12-31
Usher syndrome (USH) is the most common combination of deafness and blindness due to retinitis pigmentosa. USHIB caused by mutations in the large MYO7A gene, is among the most severe and frequent forms of USH. While deafness can be improved with cochlear implants, blindness...
Programme: H2020-EU.3.1.3.
Record Number: 212674
Last updated on: 2018-01-18
The Comparison of High-Dose Heamodiafiltration (HDF) versus Haemodialyse
ID: 754803
Start date: 2018-01-01, End date: 2022-12-31
End stage kidney disease ranks among the most severe chronic non-communicable diseases with an unmet medical need, given the high (between 10 and 15%) and stable annual mortality rates. Kidney replacement therapy is necessary when kidney function is below 10% of the normal...
Programme: H2020-EU.3.1.3.
Record Number: 212673
Last updated on: 2018-01-18
Repurposing of carbamazepine for treatment of skeletal dysplasia
ID: 754825
Start date: 2017-12-01, End date: 2022-11-30
Genetic skeletal diseases (GSDs) are an extremely diverse and complex group of rare genetic diseases that affect the development the skeleton. There are more than 450 unique and well-characterised phenotypes that range in severity from relatively mild to severe and lethal...
Programme: H2020-EU.3.1.3.
Record Number: 212675
Last updated on: 2018-01-18
Comparing effectiveness of self-management interventions in 4 high priority chronic diseases in Europe
ID: 754936
Start date: 2018-01-01, End date: 2022-12-31
COMPAR-EU aims to identify, compare, and rank the most effective and cost-effective self-management interventions (SMIs) for adults in Europe within four high-priority chronic conditions: type 2 diabetes, obesity, chronic obstructive pulmonary disease, and heart failure. This...
Programme: H2020-EU.3.1.3.
Record Number: 212679
Last updated on: 2018-01-18
Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer
ID: 733008
Start date: 2017-01-01, End date: 2022-12-31
IMMUNOSABR is geared towards opening up a new paradigm in treating metastatic cancer by obtaining clinical proof of concept for a novel bi-modal curative treatment strategy. High precision stereotactic ablative radiotherapy (SABR) is combined with immunotherapy to form a...
Programme: H2020-EU.3.1.3.
Record Number: 207443
Last updated on: 2017-07-17
Support will be provided to clinical trials on substances where orphan designation has been given by the European Commission, where the proposed clinical trial design takes into account recommendations from protocol assistance given by the European Medicines Agency, and where...
Record Number: 701988
Proposals should compare the use of currently available preventative or therapeutic (pharmacological as well as non-pharmacological) healthcare interventions in adults[[Screening and / or the involvement of elderly populations are not excluded.]]. While there is no restriction...
Record Number: 701989
12 3 4 > 
List retrieved on: 2018-01-21
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top